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Abstract
Deoxyhypusine hydroxylase (DOHH) catalyzes the final step in the post-translational synthesis of an unusual amino acid
hypusine (N
J-(4-amino-2-hydroxybutyl) lysine), which is present on only one cellular protein, eukaryotic initiation factor 5A
(eIF5A). We present here the molecular and structural basis of the function of DOHH from the protozoan parasite,
Leishmania donovani, which causes visceral leishmaniasis. The L. donovani DOHH gene is 981 bp and encodes a putative
polypeptide of 326 amino acids. DOHH is a HEAT-repeat protein with eight tandem repeats of a-helical pairs. Four
conserved histidine-glutamate sequences have been identified that may act as metal coordination sites. A ,42 kDa
recombinant protein with a His-tag was obtained by heterologous expression of DOHH in Escherichia coli. Purified
recombinant DOHH effectively catalyzed the hydroxylation of the intermediate, eIF5A-deoxyhypusine (eIF5A-Dhp), in vitro.
L. donovani DOHH (LdDOHH) showed ,40.6% sequence identity with its human homolog. The alignment of L. donovani
DOHH with the human homolog shows that there are two significant insertions in the former, corresponding to the
alignment positions 159-162 (four amino acid residues) and 174-183 (ten amino acid residues) which are present in the
variable loop connecting the N- and C-terminal halves of the protein, the latter being present near the substrate binding
site. Deletion of the ten-amino-acid-long insertion decreased LdDOHH activity to 14% of the wild type recombinant
LdDOHH. Metal chelators like ciclopirox olamine (CPX) and mimosine significantly inhibited the growth of L. donovani and
DOHH activity in vitro. These inhibitors were more effective against the parasite enzyme than the human enzyme. This
report, for the first time, confirms the presence of a complete hypusine pathway in a kinetoplastid unlike eubacteria and
archaea. The structural differences between the L. donovani DOHH and the human homolog may be exploited for structure
based design of selective inhibitors against the parasite.
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Introduction
Hypusine (N
J-(4-amino-2-hydroxybutyl) lysine) is a unique
amino acid present in the eukaryotic initiation factor 5A (eIF5A)
[1]. Hypusination of eIF5A involves spermidine dependent
biosynthesis of hypusine [2] on one specific lysine residue of
eIF5A. Hypusine formation occurs exclusively on eIF5A and is
necessary for its biological roles in cell growth and survival. It is
synthesized in two enzymatic steps [3]. The first step is catalyzed
by the enzyme deoxyhypusine synthase (DHS) [EC 2.5.1.46]
which catalyses the NAD
+ dependent transfer of the 4-aminobutyl
moiety of spermidine to a specific lysine residue of the eIF5A
precursor protein to form an intermediate, deoxyhypusine [4,5].
This intermediate is subsequently hydroxylated by the enzyme
deoxyhypusine hydroxylase (DOHH) [EC 1.14.99.29] which
completes the synthesis of hypusine and maturation of eIF5A
[6]. Disruption of the eIF5A and DHS genes has been found to be
lethal to S. cerevisiae [7,8].
The first step in the modification of lysine to deoxyhypusine is
reported to occur in all archaea. However, no orthologs of the
second enzyme, DOHH have yet been reported in the archaeal
genomes or proteomes [9]. Interestingly, despite the lack of
evidence for DOHH, archaeal species have been found to contain
either hypusine or deoxyhypusine or both [10]. On the contrary,
there is no evidence for the occurrence of deoxyhypusine or
hypusine in eubacteria. However, phylogenetic analysis showed
the presence of DHS-cognate genes in several bacterial species
[11].
The DOHH gene is found to be essential in C. elegans [12] and
D. melanogaster [13] but not in S. cerevisiae [14]. DOHH seems to be
functionally more significant in the yeast, S. pombe, in comparison
to S. cerevisiae, where a mutation in the gene caused a temperature
sensitive growth and abnormal distribution and morphology of
mitochondria [15]. The protein DOHH has only been recently
identified and characterized [14,16,17]. Unlike DHS, its catalytic
properties are not very well understood. Sequence analysis reveals
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proteins (which includes Huntingtin, Elongation Factor 3, a
subunit of Protein phosphatase 2A and target of rapamycin) and
consists of eight tandem HEAT-repeats organized in a symmet-
rical dyad [14]. It is a metalloenzyme and requires a di-iron active
center for its activity [18]. It also contains four strictly conserved
His-Glu motifs which are essential for binding iron and catalysis
[16]. Like other protein hydroxylases, DOHH is inhibited by
various metal chelators, for example mimosine, 2, 29-dipyridyl,
deferoxamine and ciclopirox (CPX). These metal chelators inhibit
HIV-1 multiplication and gene expression by inhibiting DOHH
and therefore, DOHH has been suggested as a potential target for
anti-retroviral therapy [19,20].
Leishmania donovani is a protozoan parasite and is the causative
agent of visceral leishmaniasis. The parasite life cycle consists of
two morphologically distinct stages. The promastigote forms live
inside the gut of the sandfly and the amastigote forms reside in
the macrophages of the mammalian host. The control strategy
relies mainly on chemotherapy. The existing repertoire of drugs is
limited. With the growing incidence of resistance to the existing
drugs, there is a pressing need to look for newer drugs and drug
targets. In view of the essential nature of hypusine in eukaryotic
cell growth and survival, the hypusine pathway presents a
potential new target for anti-parasitic therapy. We have recently
reported two DHS-like genes in L. donovani which show low
homology with the human DHS [21]. Both genes were cloned
and expressed, but only one, DHS34, exhibited deoxyhypusine
synthase activity. Gene replacement studies for DHS34 indicated
that the enzyme deoxyhypusine synthase and eIF5A modification
play an essential role in cell viability of this pathogenic organism
[21]. Furthermore, we also reported that the inhibitors known for
this pathway in humans are not effective against Leishmania [21].
Despite conservation of some of the active site amino acid
residues between the human and leishmanial DHS, a potent
inhibitor of human DHS, N
1-guanyl-1, 7-diaminoheptane, had
little inhibitory effect on either L. donovani proliferation or
recombinant DHS34. This finding suggests a topological
difference in the spermidine binding sites between the human
and the leishmanial enzymes and opens the possibility that the
differences between the two enzymes could be exploited for drug
development for visceral leishmaniasis.
This study combined with our previous studies, reveals that the
complete hypusine biosynthetic pathway is present in Leishmania.
We report for the first time the presence of this pathway in a
kinetoplastid. To understand the hypusine biosynthetic pathway of
L. donovani, we have cloned and characterized the second enzyme,
deoxyhypusine hydroxylase (DOHH), which completes the
synthesis of hypusine and maturation of eIF5A. Sequence analysis
of L. donovani DOHH indicates that it is highly a-helical and has
40.6% sequence identity with the human homolog. Metal
chelators like CPX and mimosine significantly inhibited the
growth of L. donovani and also the activity of recombinant DOHH
in vitro. These inhibitors were much more effective against the
L. donovani than the human enzyme. Alignment of the L. donovani
DOHH sequence with the human homolog showed two insertions
in the former and one of the insertions was found to be crucial for
its activity. Superposition of the modeled structures of human and
L. donovani DOHH showed differences in the C-terminal His-Glu
motifs. The structural differences between the L. donovani DOHH
and the human homolog might account for the differences in the
inhibitor binding properties of the parasite compared to those of
the human homolog.
Results
Sequence Analysis and Genomic Organization
Sequence analysis, database search, and alignment of the
L. donovani DOHH amino acid sequence were performed as
described in Materials and Methods. The LdDOHH amino acid
sequence had a single open reading frame consisting of 981-bp
(L. donovani DOHH, HM138676). The ORF encoded a putative
polypeptide of 326 amino acids, with a predicted molecular mass of
,36 kDa. Amino acid sequence alignment of the DOHH protein
withhomologoussequencesfromotherspeciesrevealedthatitshares
99.4% identity with L. infantum (LinJ26_V3.1920), 95.1% identity
with L. major (LmjF26.1910), 61.1% identity with T. cruzi
(Tc00.1047053507615.70), 61.2% identity with T. brucei
(Tb09.160.1240), 40.6% with H. sapiens (NP_112594) and 36.2%
with S.cerevisiae (P47120) proteins.
It was reported earlier that the human DOHH protein sequence
contains eight HEAT-repeat domains [16]. Sequence analysis of
the L. donovani DOHH protein showed the presence of eight
tandem HEAT repeats. It also showed the presence of the four
conserved His-Glu motifs, which are conserved in all eukaryotic
homologs (Figure S1). These conserved histidine and glutamic acid
residues have been reported to be absolutely necessary for catalysis
and iron binding [16]. A phylogenetic tree has been generated
(Figure S2) for the putative DOHH sequence with the other
homologous sequences. The tree indicates a closer evolutionary
relationship of L. donovani DOHH with Trypanosoma brucei (among
the kinetoplastid protozoa) and other eukaryotic pathogen species
such as Plasmodium falciparum.
The Leishmania DOHH protein sequence shares ,16% and
40.6% sequence identity with E. coli hypothetical protein YibA and
human DOHH (hDOHH) respectively. As depicted for hDOHH,
the Leishmania protein sequence also has eight HEAT repeats.
Repeats 1–4 are present in the N-terminal domain and repeats 5–
8 are present in the C-terminal domain of the protein [14].
The secondary structural features of human and L. donovani
DOHH protein sequences with respect to E. coli YibA protein are
represented in Figure 1. YibA is a predicted bacterial lyase with
HEAT-repeat structures and is not expected to possess deoxyhypu-
sinehydroxylaseactivityduetolackofactivesiteresidues.YibAwas
selectedfrompre-existingcrystalstructuredatabaseasatemplateto
model leishmanial DOHH since, of those present in the PDB, the
structure of YibA was found to be the closest to the leishmanial
DOHH. Secondary structural features of L. donovani and human
DOHHproteinsareconsistentwiththeE.colihypotheticalprotein.In
theLeishmaniaprotein,therearetwosignificantinsertionswithrespect
to the human homolog, corresponding to the alignment positions
159–162 (four amino acid residues) and 174–183 (ten amino acid
residues). The Leishmania (Figure 2A) and human DOHH protein
sequences have been modeled on the crystal structure of the YibA
(PDBid,1OYZ)proteinfromE.coli.TheE.coliproteinisconstituted
of eight HEAT-repeats forming a horse shoe shaped structure. The
Leishmania DOHH model superimposes on the template structure
witharootmeansquaredeviationof1.6 A ˚.Thegeneratedmodelof
the pathogen protein shows that the conserved His-Glu motifs are
presentintheinnercircumferenceofatoroidstructureformedbythe
repeats.Analysisofthegeneratedmodelalsosuggeststhattheamino
acid residues that are present in the inner circumference are better
conservedthanthosepresentintheoutercircumference.Moreover,
residuesthatarepresentneartheHis-Glumotifsarehighlyconserved
(Figure2C).Thisobservationsupportsthepropositionthatthecavity
formed by the His-Glu motifs-containing inner concave surface
accommodates the substrate and iron ligands. Conservation scores
foralltheaminoacidsofthepathogenproteincalculatedbyConSurf
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33138Figure 1. Comparison of the alignment and structural features of human (NP_112594) and L. donovani DOHH (ADJ39999) protein
sequences with respect to the hypothetical protein YibA (NP_290174) of Escherichia coli. This alignment gives an indication of structural
features which would be expected for the L. donovani and human DOHH protein sequences. Residues in human and L. donovani DOHH are color-
coded according to the chemical property of the amino acids. The number in parentheses after the protein code indicates the PDB residue number at
the beginning of each block. The top line shows alignment positions. The gray block corresponds to residues in alpha helices. Key to the formatted
Joy alignment of the E. coli DOHH (1OYZ) structure: Solvent inaccessible residues –UPPERCASE; Solvent accessible residues – lowercase; positive Q –
italics; cis-peptide – breve a ˘; hydrogen bond to the other side chain – tilde y ˜; hydrogen bond to the main chain amide – bold; hydrogen bond to the
main chain carbonyl – underlined; disulfide bond – cedilla s ¸.
doi:10.1371/journal.pone.0033138.g001
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33138are given as Information S1. The conservation score indicates the
evolutionaryrateofeachaminoacidresiduesite.Highconservation
implieshighconstraintsataparticularaminoacidresiduesitedueto
involvementinenzymaticactivity,ligandbindingandproteinfolding
or protein-protein interaction.
Human DOHH was also modeled using E. coli YibA as a
template and the generated model superimposed on it with a
root mean square deviation of 1.9 A ˚. The human DOHH
modeled structure was compared with the leishmanial DOHH
structure (Figure 2D). In the human protein model, the N-
terminal His-Glu motifs are present in the structurally equivalent
positions, while the C-terminal His-Glu motifs are a little further
away from the inner surface, which is suggested to accommodate
the substrate [14,16,17], as compared to the pathogen protein
where the His-Glu motifs are present in the inner circumference
of the toroid structure formed by the repeats (Figure 2D). In
addition to these topological differences in the C-terminal
domain of the human and the parasite proteins, a ten amino
acid long insertion is present in the variable loop connecting
the N- and C-terminal domains of the generated model of the
LdDOHH (Figure 2D) which might affect the specificity of the
enzyme for its substrate.
Overexpression and Purification of Leishmanial
Recombinant Deoxyhypusine Hydroxylase in E. coli
The DOHH-pET30a construct was transformed and over
expressed in E. coli BL21 (DE3) cells. A protein with an estimated
molecular weight of ,42 kDa was induced; the size correlated
well with the amino acid composition of DOHH (,36 kDa) with a
6X-His tag (,6 kDa) at the C-terminus (Figure 3A). Purification
of the DOHH protein by Ni
2+-NTA-agarose affinity chromatog-
raphy yielded ,2 mg of purified protein per liter of the bacterial
culture (Figure 3B).
Figure 2. Structure Modeling of DOHH. (A) Model of the L. donovani DOHH protein generated by using the E. coli hypothetical protein YibA
(Protein data bank accession ID: 1OYZ) as a template. As expected from the template structure, the generated model is rich in a-helices. The
conserved His-Glu motifs are colored pink and are present at the inner concave surface of a horseshoe shaped structure. The amino acid insertions
are colored yellow and are present at the outer surface and the inner concave surface of the generated model. (B) Superimposition of the L. donovani
DOHH model (cyan) and the E. coli hypothetical protein YibA (yellow). The generated model and the E. coli structure superimpose with an RMSD of
1.6 s. (C) Conservation pattern obtained for generated model of DOHH protein of L. donovani. DOHH is represented as a space-filled model and
colored according to the conservation score. Fully conserved His-Glu motifs are marked by white arrows. The coloring scheme is depicted in the
color-coding bar. All four His-Glu motifs are also represented. As is quite evident from the figure, the amino acid residues lining the inner concave
surface are quite conserved as compared to the amino acid residues present on the outer surface. (D) Structural superposition human DOHH (violet)
with that of L. donovani DOHH (Orange) is shown as a Ribbon diagram. The RMSD of the structural superposition is 4.8 A ˚. Metal chelating ‘‘HE’’ motifs
from human (Pink) and L. donovani (Cyan) are shown as spheres. The sequence insertions in the L. donovani DOHH (white) are shown as cartoons.
doi:10.1371/journal.pone.0033138.g002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33138Figure 3. Overexpression, Purification and Characterization of L. donovani DOHH protein. (A) Overexpression of DOHH protein after
induction at 3 hr with 0.5 mM IPTG. Lane 1, molecular weight marker (MBI Fermentas); Lanes 2 & 4, bacterial cell extract before induction; Lanes 3 & 5,
bacterial cell extract after induction (B) Purification of DOHH protein on Ni
2+-NTA acid affinity resin. Lane 1, molecular weight marker; Lane 2,
Flowthrough; Lane 3-4, eluted fractions showing purified DOHH protein with buffer containing 150 mM imidazole. (C) Circular dichroism spectra of
the recombinant DOHH showing that it is largely a-helical. The spectra were measured from 260 to 200 nm, at a bandwidth of 1 nm, using 100 mlo f
solution in a 0.1 mm path length cuvette and the analysis were performed as described in the Materials and Methods. (D) Comparison of the
radioactivity in aminopropionaldehyde obtained as a result of [
3H]hypusine formation after the DOHH assay with 1.0, 2.5, 5.0, 10.0 and 15.0 mg of the
recombinant L. donovani DOHH protein. The reaction was performed as described in Materials and Methods. Results are mean 6 SD of triplicate
samples. (E) Comparison of radioactivity in aminopropionaldehyde obtained as a result of [
3H]hypusine formation after the DOHH assay. The DOHH
assay reactions were carried out as described in Materials and Methods. Recombinant DOHH enzyme, purified with and without 4 mM EDTA, was
used in the absence and presence of 2 mM ferrous ammonium sulfate. The results are presented are the mean 6 SD of triplicate samples. *, p,0.05,
and ns indicates not significant (p.0.05).
doi:10.1371/journal.pone.0033138.g003
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was analyzed by Circular dichroism (CD) spectroscopy. CD
spectral analysis of the purified recombinant DOHH revealed that
it is highly a-helical, containing 77.7% a-helix (Figure 3C). The a-
helical content is very close to that reported for hDOHH (77%)
[16] showing that DOHH is a highly conserved protein. This data
also correlated with computational modeling of DOHH protein,
which suggested that the protein contains eight HEAT repeat
motifs and is largely a-helical.
Deoxyhypusine Hydroxylase Activity
The activity assay for DOHH was performed using human
eIF5A ([
3H]Dhp), obtained by carrying out the deoxyhypusine
synthase reaction using human DHS in vitro, as the substrate.
Figure 3D shows the [
3H]hypusine formation with increasing
concentration of recombinant DOHH. Recombinant DOHH
showed a specific activity of ,117 pmol h
-1 mg
-1 of DOHH. This
activity was found to be less than 10% of the values reported for
the human and the yeast enzymes [14,16].
The sequence analysis of DOHH revealed that it contains
conserved His-Glu motifs which are known to bind to divalent
ions. We analyzed the presence of any specific metal ion in the
recombinant DOHH, which might be required for its catalytic
activity, by inductively coupled plasma-high resolution mass
spectrometry (ICP-MS). Iron was found to be the major metal.
Its content was found to be ,1.2 mol of iron/ mol of DOHH.
Iron content was also measured in the recombinant LdDOHH
that had EDTA (4 mM) in the sonication buffer. The iron
content was found to be 0.5 mol of iron /mol of LdDOHH
whereas the hDOHH under similar condition had ,0.07 mol of
iron /mol of hDOHH. The content of other metals like zinc and
magnesium was also analyzed. A very low level of zinc was
found (0.034 mol/mol), whereas magnesium could not be
detected in the recombinant DOHH protein. To further
confirm that iron was indeed important for the activity of
recombinant DOHH, the activity assays of leishmanial DOHH
were performed in the presence and absence of iron as described
in the Materials and Methods. No significant increase in
recombinant leishmanial DOHH activity was observed upon
addition of ferrous ion as compared to the activity of DOHH
without the ferrous ions (Figure. 3E). However, the enzyme
when purified with EDTA in its sonication buffer showed a
marked reduction in the DOHH activity. The addition of
ferrous ion to this preparation restored its activity significantly,
indicating that the depletion of iron was the cause for the
reduced activity of the protein (Figure 3E). It thus further
confirmed that the leishmanial DOHH is an iron-binding
enzyme and requires iron for its catalytic activity.
Functional Analysis of L. donovani Mutant Recombinant
DOHH enzyme
Sequence analysis revealed the presence of a ten-amino-acid-
long insertion at the position 169–179, in the loop connecting the
N-terminal and C-terminal His-Glu motifs. A representative figure
of hDOHH and the insertions in LdDOHH is shown in Figure 4B.
The role of this insertion in L. donovani DOHH was assessed by
deletion mutagenesis. A construct LdDOHH n(A169-V179) was
created by overlapping extension PCR and the protein was
expressed and purified as described in the Materials and Methods.
Interestingly, the activity of the mutant enzyme was reduced to
,14% of the wild type recombinant enzyme, indicating that the
insertion is crucial for the activity of recombinant LdDOHH
(Figure 4C).
Effect of Inhibitors on DOHH Activity of L. donovani
In our earlier work we have shown that the inhibitors known for
the hypusine pathway in humans are not effective against
Leishmania which makes its hypusine pathway unique [21]. Despite
conservation of some of the active site amino acid residues
between the human and leishmanial DHS, a potent inhibitor of
human DHS, N
1-guanyl-1, 7-diaminoheptane, had little inhibitory
Figure 4. Effect of deletion mutation on the activity of L.
donovani DOHH. (A) Scheme representing overlap extension PCR
used for deletion of the ten-amino-acid-long insertion from LdDOHH.
The regions shown in black and green are the regions upstream and
downstream of the region to be deleted (shown in cyan blue). (B)
Alignment showing human DOHH, LdDOHH and LdDOHH n(A169-
V179). The regions that are similar between hDOHH and LdDOHH and
align with each other are shown in red, yellow and blue color. Cyan blue
color shows the insertions present in LdDOHH. (C) Comparison of the
radioactivity in aminopropionaldehyde obtained as a result of
[
3H]hypusine formation after the DOHH assay with the recombinant
LdDOHH enzyme or the mutant LdDOHH n(A169-V179) enzyme. The
results presented are the mean 6 SD of triplicate samples. *, p,0.05.
doi:10.1371/journal.pone.0033138.g004
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To assess the significance of deoxyhypusine hydroxylation in L.
donovani, the effect of known inhibitors of DOHH was examined
on the enzymatic activity of DOHH in vitro. There are no specific
inhibitors available for DOHH to date. However, it is known that,
like other hydroxylases, DOHH is also inhibited by certain metal
chelators [22,23]. The inhibitors used were the metal chelators,
mimosine, CPX and kojic acid. Mimosine, a plant alkaloid, has
been shown to inhibit the enzyme DOHH causing cell cycle arrest
at the G1-S stage in Chinese hamster ovary cells [22]. CPX is a
topical anti-fungal and is known to block DOHH activity [23].
Kojic acid has a metal chelating domain identical to that of
mimosine [22].
We investigated the effect of these inhibitors on the activity of
the recombinant deoxyhypusine hydroxylase from L. donovani. The
antifungal compound, kojic acid, was found to be ineffective in the
inhibition of DOHH activity in L. donovani (Data not shown). A
range of concentrations of both mimosine (5 mM, 10 mMo r
20 mM) and CPX (5 mM, 10 mMo r1 5mM) was used against L.
donovani recombinant DOHH. Mimosine (20 mM) and CPX
(15 mM) resulted in 70% and 60% inhibition of L. donovani DOHH
activity, respectively when compared to the control untreated
group (Figure 5A and B). Mimosine (15 mM) and CPX (15 mM)
resulted in only ,22% and ,32% inhibition of the recombinant
human DOHH (Figure. 5C and D). Interestingly, both the
inhibitors were more effective against the leishmanial enzyme as
Figure 5. Effect of mimosine and CPX on deoxyhypusine hydroxylase activity. Recombinant LdDOHH (5 mg) was incubated with either (A)
mimosine (5, 10 or 20 mM) or (B) CPX (5, 10 and 15 mM) for 10 min at 37uC. Recombinant hDOHH was incubated with varying concentrations of (C)
mimosine (20, 40, 60, 75 and 100 mM) and (D) CPX (15, 30, 45, 75 and 100 mM) for 10 min at 37uC. [
3H]Hypusine formation was then measured as
detailed in the Methods section. Results are mean 6 SD of triplicate samples. *, p,0.05; **, p,0.002 and ns indicates not significant (p.0.05).
doi:10.1371/journal.pone.0033138.g005
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(15 mM) inhibited the activity of LdDOHH and hDOHH by 60%
and 22% respectively (Figure 5C). On the other hand, CPX
(15 mM) was found to be more effective at the same concentration
and was able to inhibit LdDOHH activity by 60% and decreased
hDOHH activity by only 32% compared to the untreated
recombinant DOHH activity (Figure 5D). The inhibitor data
obtained was fitted onto the Hill equation curve to determine the
concentration of the inhibitor at which 50% of enzymatic activity
was inhibited. The concentration of mimosine and CPX that
inhibited 50% of the LdDOHH activity were 13 mM and 13.6 mM
respectively. On the other hand, when a range of concentrations of
mimosine and CPX were used against recombinant hDOHH, a
maximum of ,35% of hDOHH activity was inhibited with
concentrations as high as 100 mM (Figure 5C and D).
We then examined the effect of the inhibitors, mimosine, CPX
and kojic acid, on the cell growth of L. donovani promastigotes and
intracellular amastigotes. The antifungal compound, kojic acid,
was found to be ineffective in the inhibition of the growth of both
AG83 promastigotes and amastigotes, even at concentration as
high as 1 mM (data not shown). The concentration of mimosine as
high as 500 mM, inhibited the cell proliferation of promastigotes
by only 30% (Table 1). On the other hand, CPX was found to be
highly effective; the concentration of CPX that inhibited the
growth of WT promastigotes by 50% was ,2.1 mM (Table 1). The
effect of these inhibitors was also checked on the intracellular
amastigote form (which is the more relevant stage of the parasite).
The concentration of CPX and mimosine that inhibited the
growth of WT amastigotes by 50% was ,0.260.03 mM and
1.0960.31 mM respectively. Both CPX and mimosine at these
concentrations did not affect the viability of the macrophage cell
line THP1, the IC50 being .10 and 40 mM respectively.
Discussion
[TIGHEST]In the present study, we report for the first time the
identification and characterization of deoxyhypusine hydroxylase
from L. donovani. Sequence alignment shows that L. donovani DOHH
shares,16% and ,40.6% sequence identity with the E. coli
hypothetical protein YibA and human DOHH respectively
(Figure 1). Leishmania and human DOHH protein sequences have
been modeled on the crystal structure of YibA protein from E. coli.
The parasite and human protein models show that they are both
HEAT-repeat proteins containing eight metal coordination sites
consisting of four strictly conserved His-Glu sequences. While 3-D
structural superposition of the L. donovani and human DOHH
proteins suggests that the His-Glu motifs of the two proteins are
located in structurally equivalent positions in the N-terminal
domain, thesesequentiallyconservedmotifsarenot quite equivalent
in the C-terminal domain (Figure 2D) [17]. Furthermore, sequence
insertions that have been found at two places in L. donovani are
probably in the variable loop connecting the N- and C-terminal
domains of the protein (Figure 2D). These 3-D structural deviations
in the C-terminal domain along with the ten-amino-acid-residue-
long insertion in the inner concave surface of generated model
might account for the differences in the inhibitor binding properties
oftheparasite enzymefromthat ofthe humanhomolog.Deletion of
this ten-amino-acid-long insertion reduced the DOHH activity of
the enzyme to 14% of the activity of the wild type, indicating that it
is critical for its activity (Figure 4C).
A single gene for DOHH is present in all eukaryotic organisms
and is quite conserved. It is absent from archaea and bacteria,
though DHS-like genes are found in archaea and certain bacteria
[11]. Deoxyhypusine hydroxylase belongs to a family of proteins
that contain tandem repeats of HEAT motifs. Human DOHH is
composed of two symmetrical domains, each containing four
HEAT-repeats. It depends on Fe
2+ ions for its activity and has four
strictly conserved His-Glu pairs that act as metal co-ordination
sites [14]. The residues His-56, His-89, Glu-90, His-207, His-240,
and Glu-241 of human DOHH have been identified as iron
coordination sites. Sequence analysis of L. donovani DOHH showed
low sequence identity with the human homolog. It also contains
eight tandem HEAT repeats, four in each N- or C- terminal
domain. Plasmodium DOHH is an exception as it has been reported
to have 5 HEAT-repeats instead of eight [24]. Sequence analysis
of the L. donovani DOHH indicates the presence of four His-Glu
motifs corresponding to the residues present in the human
homolog. These observations suggest that L. donovani DOHH is
also a metalloenzyme. Therefore, we studied the effect of metal
chelators on both the activity of L. donovani recombinant DOHH
and cell growth. Mimosine and CPX strongly inhibited the activity
of recombinant DOHH in vitro. Interestingly, we found that both
the compounds inhibited the leishmanial DOHH more effectively
as compared to the human counterpart. The differences in
sensitivity could be due to differences in the interactions of the
compounds with each of the enzymes and may be exploited for
anti-parasitic effects. The inhibition of enzymatic activity of
DOHH in vitro by CPX correlated well with the inhibition of cell
proliferation of AG83 promastigotes as well as intracellular
amastigotes (Table 1). Mimosine, which inhibited recombinant
DOHH activity in vitro, also inhibited the cell growth of
intracellular amastigotes effectively (IC50=1.0960.31 mM). In
contrast, it was a poor inhibitor of the growth of promastigotes,
even at a much higher concentration (IC50 .500 mM). The reason
for the difference may be due to differences in the efficiency of
their uptake into the cells. Since mimosine and CPX are metal
chelators and not specific inhibitors for DOHH enzyme, it is
possible that they may have off-target effects in the Leishmania
parasites and might inhibit other enzymes as well, leading to
inhibition of cell growth of promastigotes and intracellular
amastigotes. However, both CPX and mimosine, at concentra-
tions 10 and 40 mM, respectively, did not show any effect on
uninfected human macrophage-like THP-1 cells in vitro. Kojic
acid, whose metal chelating domain is identical to mimosine, failed
to show any effect on DOHH activity in vitro or growth (data not
shown). This observation correlates with earlier studies establish-
ing that the compounds must have a planar ring and an amino
side chain to effectively inhibit DOHH [22].
DOHH is the second enzyme in the hypusine pathway and
catalyzes the maturation of eIF5A, which has been found to be an
essential protein in cell proliferation. Inhibitors of DOHH have
been shown to have anti-proliferative effects in mammalian cells,
Table 1. Effect of mimosine and CPX on promastigotes,
amastigotes of Leishmania donovani and on human
macrophage-like cell line THP-1.
IC50 (mM)
Inhibitor Promastigotes
Intracellular
Amastigotes
Uninfected
Macrophages
Mimosine .500 1.0960.31 .40
CPX 2.1460.21 0.260.03 .10
IC50s were determined 72 h after drug addition as reported in the Materials
section.
Results are Mean 6 Standard deviation of triplicate values.
doi:10.1371/journal.pone.0033138.t001
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importance of hypusine modification in eukaryotic cells [22]. Metal
chelating inhibitors of DOHH, such as deferiprone and CPX, have
been shown to have anti-retroviral effects by inhibiting DOHH
activity in cells thereby depleting cellular eIF5A levels and ultimately
affecting mRNA translation [19]. Therefore, eIF5A and DOHH
have been proposed as targets for anti-tumor and anti-retroviral
chemotherapy [19,20]. Molecular cloning of DOHH from L.
donovani indicatesthatthe entirehypusine biosyntheticpathwayexists
in this organism. We have earlier demonstrated that the first enzyme
of the pathway, DHS, plays a vital role in survival and proliferation
of L. donovani [21] and it is probale that DOHH is also vital in L.
donovani. However, DOHH unlike DHS is not essential in S. cerevisiae
[14]. Whether the leishmanial DOHH is essential or not can not be
assumed at this stage and needs further verification.
The ability to regulate cell growth by inhibition of DOHH may
provide us with a chemotherapeutic target. Our results demon-
strate that both CPX and mimosine exhibited selective activity
against the pathogen and not against the host. Further studies are
required to investigate the structure of the enzyme and its
mechanism of action in order to develop selective inhibitors
against the parasite.
Materials and Methods
Chemicals
Radiolabeled spermidine trihydrochloride [1,8-
3H]spermidine
(32.35 Ci/mmol) was purchased from PerkinElmer Life Sciences.
MTT, [3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bro-
mide] was purchased from Sigma (St. Louis, MO). CENTA
TM, b-
lactamase substrate was purchased from Calbiochem (La Jolla,
CA). The compounds mimosine, CPX and kojic acid were
purchased from Sigma Aldrich (St. Louis, MO). All restriction
enzymes and DNA modifying enzymes were obtained from MBI
Fermentas (Germany). The other materials used in this study were
of analytical grade and were commercially available.
Parasite and Culture Conditions
L. donovani AG83 (MHOM/IN/1983/AG83) promastigotes
were cultured at 22uC in modified M199 medium (Sigma)
supplemented with 100 U/ml penicillin (Sigma), 100 mg/ml
streptomycin (Sigma) and 10% heat inactivated fetal bovine
serum (FBS, Hyclone).
Effect of Inhibitors on the Growth of Promastigotes of
L. donovani
The effect of inhibitors of DOHH on the growth of L. donovani
AG83 promastigotes was determined by the MTT assay. 25 mlo f
1610
6 parasites/ml of mid log phase promastigotes were cultured
in 96 well tissue culture plate and incubated with 25 ml of varying
concentrations of CPX, mimosine and kojic acid at 22uC. After 72
h, 20 ml of 5 mg/ml MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide] dissolved in phosphate buffered
saline (pH 7.2) was added. Plates were incubated at 37uC until
purple-colored crystals were formed. The reaction was stopped by
the addition of 50 ml of 50% isopropanol and 10% sodium dodecyl
sulfate with gentle shaking at 37uC for 1 h. Absorbance was
measured spectrophotometrically at 570 nm.
Intracellular Amastigote-Macrophage Cultures and Drug
Effect
THP-1 human macrophage-like cell line was obtained from
ATCC and maintained in RPMI- 1640 medium (Sigma)
supplemented with 10% FBS at 37uCi n5 %C O 2 atmosphere.
Before infection, 200 mlo f5 610
5 cells/ml cells were plated in 96-
well plates and differentiated with phorbol myristic acetate (PMA)
(20 ng/ml). They were allowed to adhere for 48 h and were
infected with stationary phase AG83 promastigotes transfected
with the b-lactamase gene at a ratio of 20 parasites per monocyte,
as reported earlier [25]. After 6 h of infection, the non-
internalized parasites were washed off with RPMI medium and
different concentrations of drugs were added. Intracellular
amastigotes grown in THP-1 cell lines were quantified after 72
h of drug addition for b-lactamase activity by first removing the
medium by gentle pipetting. Subsequently, 50 mlo f5 0 mM
CENTA
TM in 1X PBS and 0.1% Nonidet P-40 were added. The
plates were incubated at 37uC for 4 h and the absorbance was
read at 405 nm.
Cloning of Putative Deoxyhypusine Hydroxylase Gene
(DOHH) from L. donovani
A 981- bp DNA fragment encompassing the whole open
reading frame (ORF) of L. donovani DOHH gene was amplified
from the genomic DNA using a sense primer with a flanking EcoRI
site, 59- CGGAATTC ATGTCTGCTTTGAACAGCCGCAC-
CGTCGA-39 and an antisense primer with a flanking HindIII site,
59-CCCAAGCTTCCTGTTGAACACCCCTCTCACGCCTC-
CTG-39. The amplified product was obtained and subcloned into
the pTZ57R/T (MBI Fermentas) vector and subjected to auto-
mated sequencing.
Construction of L. donovani Deoxyhypusine Hydroxylase
Mutant Gene
Sequence analysis revealed the presence of a ten-amino-acid
long insertion at the position 169-179 in the loop connecting the
N-terminal and C-terminal His-Glu motifs. To study the
importance of this insertion in the L. donovani DOHH protein,
deletion mutagenesis was performed by the overlap extension
PCR method as described by [26]. The basic scheme of the PCR
is described in Figure 4A. The PCR primers used were: P1: 59-
CGGAATTC ATGTCTGCTTTGAACAGCCGCACCGTCG-
A-39; P2: 59- GGTGTGCGG GCTAAACGCCGGCGACG-
GATCCACAGAC-39; P3: 59-GCGTTTAGC CCGCACACC-
GTGGAGGAACTGGAG-39; P4; CCCAAGCTTCCTGTTG-
AACACCCCTCTCACGCCTCCTG-39. The final PCR product
was obtained and cloned into pET30a vector (Novagen) and
subjected to automated sequencing.
Sequence and Structure Analysis
In order to facilitate the comparative analysis of DOHH protein
sequences from diverse eukaryotic organisms, the DOHH protein
sequence from L. donovani was searched using the PSI-BLAST
approach [27] in the Uniref90 sequence database, which is a
comprehensive collection of protein sequences from diverse
organisms (www.ebi.ac.uk/uniref/). The CD-HIT program [28]
was used to generate a non-redundant dataset of homologous
DOHH sequences with the sequence identity cut off of 90%. The
multiple sequence alignment program CLUSTALW [29] was used
to align DOHH sequences from different sources. A phylogenetic
tree was generated using a neighbor-joining (NJ) method [30]. The
MEGA program (version 4.0) was used to draw the tree [31]. The
tree was annotated with bootstrap values (1000 iterations). The
Program JOY [32] was used for displaying the three-dimensional
structural features of the human DOHH and Leishmania DOHH
protein sequences with respect to the crystal structure of the E. coli
YibA protein.
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was confirmed using the fold recognition approach PHYRE
(Protein Homology/analogY Recognition Engine) version 0.2
[33]. PHYRE fitted the pathogen DOHH sequence on the
structure of the hypothetical Escherichia coli protein, YibA (PDB
accession code: 1OYZ) with very high reliability (estimated
precision 100%) and reliable E-value (10
-18). Leishmania and
human protein sequences were modeled on the tertiary structure
of the E. coli protein template using MODELLER version 9.0 (Sali
Lab, UCSF, San Francisco, CA, USA, http://www.salilab.org/
modeller) [34]. The generated models were energy minimized
using Kollman united atom forced field in SYBYL [Tripos Inc., St.
Louis, MO, USA] to relieve short contacts, if any.
The generated models were superimposed on a template
structure by using DaliLite program [35]. The overall fit of the
sequence to the modeled structure was checked using PROSA
[36,37]. The stereochemistry of the energy-minimized models was
ensured using PROCHECK [38,39]. The Leishmania DOHH
protein model thus generated was analyzed using ConSurf
(Conservation Surface Mapping Method) [40], which maps the
conserved regions on the surface of a protein structure based on
phylogeny among related sequences. Structural visualization was
performed using the PYMOL program {DeLano W L 83 /
id}[41]. 3-D structural models of the human protein and L.
donovani are compared using the DaliLite program [31]. Structural
models superposed with a Z-score of 29.2 and an RMSD of 4.8 A ˚.
The structure-based sequence identity of the human and parasite
protein is 18%.
Construction of L. donovani DOHH Expression Vector and
Purification of the recombinant and the mutant DOHH
Protein
The coding region of DOHH gene was subcloned into EcoRI-
HindIII site of pET30a vector (Novagen). The fidelity of the PCR-
amplified L. donovani DOHH was confirmed by automated DNA
sequencing. The constructs containing either wild type DOHH or
mutant DOHH were transformed into the BL21 (DE3) strain of E.
coli. Protein expression for both the constructs was induced by
0.5 mM isopropyl-1-b-d-galactopyranoside (IPTG) at 37uC for 3
h. Bacteria were then harvested by centrifugation at 50006g for 10
min and the cell pellet was resuspended in binding buffer (50 mM
Tris.Cl pH 7.5, 10 mM imidazole, 300 mM sodium chloride, 1
mM phenylmethylsulfonyl fluoride (PMSF) and 30 ml of protease
inhibitor cocktail (Roche Applied Sciences, Germany). The
resulting cell suspension was sonicated six times for 15 s with
1 min intervals. The lysate was centrifuged at 10,0006g for
30 min at 4uC. The resulting supernatant, which contained the
protein, was loaded onto pre-equilibrated Ni
2+-Nitrilotriacetic acid
(NTA) – agarose resin (Qiagen). The mixture was kept on a
rocking platform for 2 h at 4uC. It was centrifuged at 4006g for
1 min at 4uC. The supernatant was removed and the resin was
washed three times with wash buffer (50 mM Tris.Cl, pH 7.5,
20 mM imidazole, 300 mM NaCl, 1 mM PMSF and protease
inhibitor cocktail). The proteins were eluted with increasing
concentrations of imidazole. Imidazole was removed by dialysis
and the purified proteins were found to be .95% pure as judged
by SDS-PAGE gel.
For metal analysis, a large scale preparation of the enzyme was
carried out. Two preparations of the recombinant protein were
made: one as described above and the second preparation
included 4 mM EDTA in the sonication buffer. The buffers used
for purification were made in metal-free HPLC water. The
purification procedure followed was the same as described above.
Purification of Human Recombinant Deoxyhypusine
Hydroxylase
The plasmid construct encoding the human enzyme hDOHH-
pGEX-4T-3 was transformed into E. coli BL21 cells and the
protein was over expressed and purified with a GST tag as
described earlier [16]. The purified protein was then treated with
the RECOMT Thrombin CleanCleave
TM Kit (Sigma) and the
GST tag was removed according to the manufacturer’s protocol.
Analysis of Secondary Structure of DOHH by Circular
Dichroism
Circular dichroic spectra were measured in a Chirascan
TM
circular dichroism spectrometer. Far ultraviolet spectra were
measured from 260 to 200 nm, bandwidth of 1 nm, using 100 ml
of solution in a 0.1 mm path length cuvette. The protein
concentration was measured spectrophotometrically and used at
0.6 mg/ml. Data were obtained in milli degrees and converted
into Delta Epsilon (De) for estimation of secondary structure using
CDNN software using a mean residue weight of 113.
Preparation of Radiolabeled eIF5A (Dhp) Substrate for
DOHH Assay
Polyhistidine-tagged human eIF5A and human deoxyhypusine
synthase used for the preparation of radiolabeled eIF5A (Dhp)
substrates were purified as described [42]. The human eI-
F5A([
3H]Dhp) was prepared by an in vitro deoxyhypusine synthase
reaction using [
3H]spermidine as described previously [43]. Since
human eIF5A(Dhp) acts as an effective substrate for Leishmanial
DOHH, it was used for the assay of the Leishmanial enzyme.
Deoxyhypusine Hydroxylase Assay
The activity of the recombinant purified deoxyhypusine
hydroxylase was measured as the formation of radioactive
aminopropionaldehyde after periodate oxidation of the hypu-
sine-containing product, eIF5A([
3H]Hpu), formed following the
DOHH reaction [44]. A typical DOHH reaction mixture
contained 20 mM Tris.Cl pH 7.5, 6 mM DTT, 1 mg/ml BSA,
radiolabeled protein substrate, human eIF5A ([
3H] Dhp) (2-
4610
4 cpm) and 1-15 mg of purified enzyme in 40 ml of total
volume. After incubation in a 37uC water bath for 2 h, the
reaction mixture was divided into two halves. To the first half of
the reaction mixture, 250 mg of BSA was added followed by
precipitation with 100 ml of 10% trichloroacetic acid. To the other
half of the reaction mixture, 40 ml of 0.2 M sodium phosphate/
citrate buffer, pH 6.4, and 15 ml of 0.3 M sodium meta-periodate
were added and kept at RT for 2 h. The reaction was stopped by
adding 250 mg of BSA followed by precipitation with 200 mlo f
10% TCA. The TCA precipitates from both reactions were
centrifuged at 15,0006g at 4uC and the counts were recorded with
a liquid scintillation counter. The radioactivity in the TCA
supernatant of an unoxidized sample was subtracted from that of
the oxidized sample to calculate the net hypusine formed [44].
The assay was performed in the presence or absence of an
inhibitor. The reaction mixture was pre-incubated with varying
concentrations of mimosine or CPX at 37uC for 10 min and then
the substrate, eIF5A([
3H]Dhp), was added and the reaction was
carried out in a 37uC water bath for 2 h. The rest of the assay was
performed as described above.
Analysis of the Metal Content of DOHH
The buffers for the recombinant LdDOHH enzyme were
prepared using metal-free HPLC water. The protein samples were
analyzed for metal content (Iron, magnesium and zinc) by
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(ICP-MS) (ARBRO Pharmaceuticals Ltd, New Delhi, India). To
further confirm if iron is required for the DOHH activity, activity
assays were performed with two different DOHH preparations.
The enzyme preparation was done in the presence and absence of
4 mM EDTA in the sonication buffer. The activity assays were
performed in the presence and absence of ferrous ammonium
sulphate (2 mM). The DOHH enzyme assay was set up as
described above.
Statistical Analysis
T-test was performed using Graph-Pad Prism version 5.0 for
Windows to determine the P- values. Values of p,0.05 were
consideredstatisticallysignificant.Dataarepresentedasmean6SD.
Supporting Information
Figure S1 Multiple sequence alignment of deoxyhpusine
hydroxylase protein sequences from Leishmania dono-
vanialongwithitseukaryotichomologs.Conserved His-Glu
motifs are highlighted in yellow. Apart from the His-Glu motifs,
other absolutely conserved residues are highlighted in gray.
Accession numbers and the corresponding organism as the source
of the DOHH used in generating the multiple sequence alignment
are as follows: B0S4Z5_DANRE: Danio_rerio, B0W942_CULQU:
Culex_quinquefasciatus, B2WFV6_PYRTR: Pyrenophora_tritici-repentis,
B6K221_SCHJY: Schizosaccharomyces japonicus, B9WC15_CANDC:
Candida_dubliniensis, C0SAR9_PARBP: Paracoccidioides brasiliensis,
C1BJA2_OSMMO: Osmerus mordax, C1BQB5_9MAXI: Caligus
rogercresseyi, C1BVM4_9MAXI: Lepeophtheirus salmonis, C4R113_
PICPG: Pichia pastoris, C5FM15_NANOT: Nannizzia otae,
C5K274_AJEDS: Ajellomyces dermatitidis, C8VBH9_EMENI: Asper-
gillus nidulans, C9QNK6_PLAFO: Plasmodium falciparum, D0NC43_
PHYIN: Phytophthora infestans, DOHH1_ORYSJ: Oryza sativa subsp.
japonica, DOHH_ARATH: Arabidopsis thaliana, DOHH_ASHGO:
Ashbya gossypii, DOHH_ASPCL: Aspergillus clavatus, DOH-
H_ASPFU: Aspergillus fumigatus, DOHH_ASPNC: Aspergillus niger,
DOHH_ASPOR: Aspergillus oryzae, DOHH_BOVIN: Bos taurus,
DOHH_CAEEL: Caenorhabditis elegans, DOHH_CANGA: Candida
glabrata, DOHH_CHAGB: Chaetomium globosum, DOHH_CHICK:
Gallus gallus, DOHH_COCIM: Coccidioides immitis, DOHH_
CRYNE: Cryptococcus neoformans, DOHH_DEBHA: Debaryomyces
hansenii, DOHH_DICDI: Dictyostelium discoideum, DOHH_
DROME: Drosophila melanogaster, DOHH_ENCCU: Encephalitozoon
cuniculi, DOHH_GIBZE: Gibberella zeae, DOHH_HUMAN: Homo
sapiens, DOHH_KLULA: Kluyveromyces lactis, DOHH_LENED:
Lentinula edodes, DOHH_MOUSE: Mus musculus, DOHH_NEUCR:
Neurospora crassa, DOHH_PHANO: Phaeosphaeria nodorum, DOHH_
SCHPO: Schizosaccharomyces pombe, DOHH_USTMA: Ustilago
maydis, DOHH_XENLA: Xenopus laevis, DOHH_YARLI: Yarrowia
lipolytica, DOHH_YEAST: Saccharomyces cerevisiae, Q4Q901_
LEIMA: Leishmania major, A4I2C0_LEIIN: Leishmania infantum and
Q38FR2_9TRYP: Trypanosoma brucei.
(PDF)
Figure S2 Phylogenetic analysis of DOHH protein
sequences from different eukaryotic sources. The phylo-
gram presented is a consensus of 1000 bootstrap replicates
constructed using the MEGA program (Ver. 4.0). The numbers
at the node present the percentage of trees with the same node
among all the bootstraps. L. donovani DOHH protein sequence
clusters with other eukaryotic pathogens such as Plasmodium
falciparum and Trypanosoma brucei.
(PDF)
Information S1 Amino Acid Conservation Scores.
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